Who is sponsoring NCT03733886?

NCT03733886 is sponsored by Oslo University Hospital.

What drugs are being tested in NCT03733886?

Interventions in NCT03733886: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10).

What condition does NCT03733886 study?

NCT03733886 studies Peripheral Neuropathic Pain, Radiculopathy, Lower Back Pain.

Is NCT03733886 still recruiting?

NCT03733886 is currently completed. Last updated 30 August 2023.

Last reviewed 2023-08-30 · How we verify

NCT03733886

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Burst Spinal Cord Stimulation for Neuropathic Pain.

Completed NA Last updated 30 August 2023

What this trial tests

NA trial testing Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10) in Peripheral Neuropathic Pain in 10 participants. Completed in 22 June 2023.

Timeline

9 September 2019

Primary endpoint
22 June 2023

22 June 2023

Quick facts

Lead sponsor	Oslo University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	10
Start date	9 September 2019
Primary completion	22 June 2023
Estimated completion	22 June 2023
Sites	2 locations across Sweden, Norway

Drugs / interventions tested

Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10)

Conditions studied

Peripheral Neuropathic Pain — all drugs for Peripheral Neuropathic Pain →
Radiculopathy — all drugs for Radiculopathy →
Lower Back Pain — all drugs for Lower Back Pain →

Sponsor

Oslo University Hospital

Who can join

Adults 18 to 80, any sex, with Peripheral Neuropathic Pain or Radiculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the effect of Burst spinal cord stimulation (SCS) in the treatment of painful radiculopathy in lower extremity(ies) with or without lower back pain. It is a multicenter double-blinded "n-of-1" RCT with repeated two-week periods of Burst SCS or sham in randomised order.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Implanted spinal neuromodulation interventions for chronic pain in adults.
O'Connell NE, Ferraro MC, Gibson W, Rice AS, et al · · 2021 · cited 43× · PMID 34854473 · DOI 10.1002/14651858.cd013756.pub2

Verify or expand the search:

Other recruiting trials for Peripheral Neuropathic Pain

Currently open trials in the same condition.

NCT07160049 — Wearable Focused Ultrasound Stimulation for Peripheral Nerve Pain Management · NA · active not recruiting
NCT06964243 — Protocol Assessment of Motor Cortex rTMS for Treating Neuropathic Pain · NA · recruiting
NCT05817591 — Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or W · recruiting
NCT05351801 — Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain · Phase 2 · recruiting
NCT06290661 — Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pai · NA · recruiting

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03733886 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 30 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03733886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing